Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole PR dose response in early Parkinson's disease
NCT01485172Phase 4Completed
- Sponsor
- GSK
- Start
- Jan 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of ropinirole in Parkinson's disease (PD), sponsored by GSK. Started Jan 2012; status: completed.
02
Drugs
ropinirole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01485172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01485172.